MSD鈥檚 Gardasil sales slide further due to China constraints
MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Regeneron partners with Fujifilm to broaden manufacturing capacity
Top 20 biopharmas鈥� market cap rises 6% in Q1 2025 amid tariff headwinds
Pharma companies in Europe push for US-level drug prices
Repertoire and Genentech to develop autoimmune disease therapies
色界吧
View More
Themes
View MoreEli Lilly and BigHat Biosciences ink AI antibody discovery deal
The agreement adds to Eli Lilly鈥檚 growing portfolio of AI-enabled drug discovery partnerships.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View MoreDigital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
EU Health Data Space strikes a chord in EU harmonisation plans
Mastering compliance and copyright in healthcare and MedComms
AstraZeneca director says AI must be a 鈥渢hought partner鈥� in drug discovery